Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 5.03
- Piotroski Score 6.00
- Grade Underweight
- Symbol (CAPL)
- Company CrossAmerica Partners LP
- Price $20.11
- Changes Percentage (-0.45%)
- Change -$0.09
- Day Low $20.04
- Day High $20.30
- Year High $24.19
CrossAmerica Partners LP engages in the wholesale distribution of motor fuels, operation of convenience stores, and ownership and leasing of real estate used in the retail distribution of motor fuels in the United States. It operates in two segments, Wholesale and Retail. The Wholesale segment engages in the wholesale distribution of motor fuels to lessee dealers, independent dealers, commission agents, and company operated retail sites. The Retail segment is involved in the sale of convenience merchandise items; and retail sale of motor fuels at company operated retail sites and retail sites operated by commission agents. As of December 31, 2021, the company distributed motor fuel on a wholesale basis to approximately 1,750 sites located in 34 states; and owned or leased approximately 1,150 sites. CrossAmerica GP LLC operates as the general partner of the company. The company was formerly known as Lehigh Gas Partners LP and changed its name to CrossAmerica Partners LP in October 2014. The company was founded in 1992 and is based in Allentown, Pennsylvania.
- Last Earnings 10/23/2024
- Ex-Dividend for 5/16 Dividend 11/04/2024
- Dividend Payable 11/13/2024
- Today N/A
- Next Earnings (Estimated) 02/24/2025
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $0.61
- Trailing P/E Ratio 33.2
- Forward P/E Ratio 33.2
- P/E Growth 33.2
- Net Income $40.10 M
Income Statement
Quarterly
Annual
Latest News of CAPL
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Intra-Cellular bolsters Caplyta data with another Phase III win
Intra-Cellular Therapeutics reports positive results from a Phase III trial of Caplyta for preventing relapse in schizophrenia patients. The study showed a 63% reduction in relapse risk with Caplyta c...
By Yahoo! Finance | 1 week ago
